The Veterinary Molecular Diagnostics Market is expected to grow at a CAGR of 9.2% from 2022 to 2029 to reach $1.13 billion by 2029. Factors such as the growing pet animal population, high animal healthcare expenditure, ongoing advancements in veterinary molecular diagnostics, and the high sensitivity and specificity of MDx tests are supporting the market growth. Moreover, emerging markets, advancements in veterinary diagnostics technologies, and increasing efforts by organizations to promote animal welfare are expected to offer opportunities for the global veterinary molecular diagnostics market.
Since the outbreak of COVID-19, SARS-CoV-2 infections have been reported in a small number of animals worldwide, mostly in animals that had close contact with a sick person with COVID-19. As the COVID-19 outbreak continues to take its toll on global markets, the veterinary molecular diagnostics market will be affected in the upcoming years as there is a surge in the development of veterinary diagnostics products for protecting and animal diagnosis.
Few pet cats and dogs have been infected with the virus in several countries, including the U.S. For instance, in June 2020, the United States Department of Agriculture’s (USDA) National Veterinary Services Laboratories (NVSL) reported the first confirmed case of SARS-CoV-2 (the virus that causes COVID-19) infection in a pet dog (German shepherd) in New York state. Similarly, in April 2020, the U.S. Centers for Disease Control and Prevention (CDC) and the United States Department of Agriculture’s (USDA) National Veterinary Services Laboratories (NVSL) announced confirmed cases of SARS-CoV-2 (the virus that causes COVID-19) infection in two pet cats which got infected as their owner had tested positive for COVID-19.
The animals are being tested for SARS-CoV-2 infection and tested to see whether the pet develops antibodies to this virus. Various molecular diagnostics-based assays are being developed for testing infection in animals. For instance, in April 2020, IDEXX Laboratories, Inc. (U.S.) launched the IDEXX SARS-CoV-2 (COVID-19) RealPCR Test for pets.
Thus, several studies are underway to learn more about coronavirus infection in animals. This is expected to lead to the development of various molecular diagnostics-based assays and kits for testing, leading to increased adoption of veterinary molecular diagnostic products.
Click here to: Get Free Request Sample Copy of this report
Rising Prevalence of Zoonotic Diseases to Drive the Growth of the Veterinary Molecular Diagnostics Market
Global urbanization is causing increasingly frequent contact between wildlife, human and domestic animal populations, resulting in increased zoonotic disease spillover from wildlife populations. Animal rearing, slaughter, preparation, and food consumption practices can further promote the transmission of infectious animal and zoonotic diseases. Animals can sometimes appear healthy even when carrying germs that make people sick, depending on the zoonotic disease. As animals also provide food for consumption, foodborne zoonotic diseases are caused by consuming food or water contaminated by pathogenic microorganisms. According to CDC, more than 6 out of every ten known infectious diseases in people can be spread from animals, and 3 out of every four new or emerging infectious diseases in people come from animals.
According to WHO, an estimated 600 million, i.e., almost 1 in 10 people worldwide, fall ill from consuming contaminated food every year. Children under five years of age are at a particularly high risk of carrying 40% of the burden of foodborne diseases, with 125,000 children dying from foodborne diseases every year. Diarrheal diseases are the most common illnesses resulting from the consumption of contaminated food, causing 550 million people to fall ill and 230,000 deaths every year (Source: WHO). According to the Centers for Disease Control (CDC), in 2020, nearly 18,462 foodborne disease infections were witnessed in the U.S., including 4,788 hospitalizations and 118 deaths. Also, WHO states that the total productivity loss associated with foodborne disease in low-and middle-income countries was USD 110 billion in 2020.
As zoonotic diseases spread from animals to humans and from humans to animals, 61% of the infectious diseases affecting humans are zoonotic; 75% of new or emerging diseases worldwide are zoonotic. Thus, PoC diagnosis and management decisions can prevent onward transmission of infectious pathogens, protecting the health and wellbeing of human and animal populations worldwide and potentially containing epidemics that would otherwise have serious and far‐reaching consequences.
In 2022, the Polymerase Chain Reaction Segment is Estimated to Dominate the Veterinary Molecular Diagnostics Market
On the basis of technology, the PCR segment is estimated to account for the largest share of this market in 2022. PCR tests are used in the early stages of an infection, where the level of infection is often below the detection limit (or in the latent phase) of conventional methods. It gives an immediate response to the current infection i.e. PCR offers information about the animal’s current infection status and therefore offers significant value to veterinarians and farmers. The use of techniques, such as PCR and real-time PCR, has led to the development of assays that decrease the problems associated with cross-contamination among samples and facilitates. Thus, these factors are expected to drive the market for this segment.
Based on Product, the Kits & Reagents Segment is Estimated to Grow at the Highest CAGR During the Forecast Period
On the basis of product, in 2022, the kits & reagents segment is estimated to account for the largest share of the veterinary molecular diagnostics market. The large share of this segment is mainly attributed to the fact that they are frequently used and the availability of a diverse range of reagents and consumables for various diseases.
In 2022, the Companion Animals Segment is Estimated to Account for the Largest Share of the Veterinary Molecular Diagnostics Market
On the basis of animal type, the companion animals segment is estimated to account for the largest share of the market in 2022. Companion animals can act as a carrier of diseases that infect humans (i.e. zoonotic disease). Therefore, the care and concern by pet owners regarding the health and wellbeing of companion animals are increasing. In recent years, infection of various diseases in companion animals has increased, leading companion diagnostic providers to develop new devices and tests. Also, increasing awareness among pet owners to regularly diagnose glucose levels increases the demand for glucose monitors. Further, companies are developing newer diagnostic products, helping expand the segment.
Asia Pacific: Fastest-growing Market
The factors driving the growth of the Asia-Pacific veterinary molecular diagnostics market are the large population of livestock animals, rising incidence of various zoonotic diseases, and focus on adopting newer molecular technologies in animal healthcare.
Key Players
The report includes a competitive landscape based on extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments in leading industry market players over the past four years . The key players profiled in the global veterinary molecular diagnostics market are IDEXX Laboratories, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), bioMérieux S.A. (France), Neogen Corporation (U.S.), Heska Corporation (U.S.), Biomedica Medizinprodukte GmbH & Co KG (Austria), VCA, Inc. (U.S.), Novacyt Group (U.K.), QIAGEN N.V. (Germany), and BioChek B.V (Netherlands).
Scope of the Report:
Veterinary Molecular Diagnostics Market, by Product
Veterinary Molecular Diagnostics Market, by Application
Veterinary Molecular Diagnostics Market, by Technology
Veterinary Molecular Diagnostics Market, by Animal Type
Veterinary Molecular Diagnostics Market, by End User
Veterinary Molecular Diagnostics Market, by Geography
Key questions answered in the report:
The global veterinary molecular diagnostics market is projected to reach $1.13 billion by 2029, at a CAGR of 9.2% during the forecast period.
This report provides pre & post COVID-19 market estimates.
1. Introduction
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency
2. Research Methodology
2.1. Research Process
2.2. Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research
2.3. Market Assessment
2.3.1. Market Size Estimation
2.3.1.1. Bottom-Up Approach
2.3.1.2. Top-Down Approach
2.3.1.3. Growth Forecast
2.3.2. Market Share Analysis
2.4. Assumptions for the Study
2.5. Limitations for the Study
3. Executive Summary
4. Market insights
4.1. Market Overview
4.2. Drivers
4.2.1. Growing Pet Animal Population
4.2.2. High Sensitivity and Specificity of MDx Tests
4.2.3. High Animal Healthcare Expenditure
4.2.4. Ongoing Advancements in Veterinary Molecular Diagnostics
4.3. Restraint
4.3.1. High Cost of Molecular Diagnostics Instruments
4.4. Opportunity
4.4.1. Emerging Markets
4.4.2. Advancements in Diagnostic Methods
4.4.3. Increasing Efforts by Organizations to Promote Animal Welfare
4.5. Challenge
4.5.1. Dearth of Veterinary Practitioners in Emerging Countries
4.6. Impact of COVID–19 Pandemic
5. Veterinary Molecular Diagnostics Market, by Product
5.1. Introduction
5.2. Kits & Reagents
5.3. Instruments
5.4. Software
6. Veterinary Molecular Diagnostics Market, by Application
6.1. Introduction
6.2. Infectious Diseases
6.3. Metabolic Diseases
6.4. Genetics
6.5. Other Applications
7. Veterinary Molecular Diagnostics Market, by Technology
7.1. Introduction
7.2. Polymerase Chain Reaction (PCR)
7.3. Microarray
7.4. DNA Sequencing
8. Veterinary Molecular Diagnostics Market, by Animal Type
8.1. Introduction
8.2. Companion Animals
8.3. Livestock Animals
9. Veterinary Molecular Diagnostics Market, by End User
9.1. Introduction
9.2. Veterinary Hospitals
9.3. Clinical Laboratories
9.4. Research Institutes
10. Veterinary Diagnostics Market, by Geography
10.1. Introduction
10.2. North America
10.2.1. U.S.
10.2.2. Canada
10.3. Europe
10.3.1. Germany
10.3.2. France
10.3.3. U.K.
10.3.4. Italy
10.3.5. Spain
10.3.6. Rest of Europe (ROE)
10.4. Asia–Pacific
10.4.1. Japan
10.4.2. China
10.4.3. India
10.4.4. Rest of Asia–Pacific
10.5. Latin America
10.6. Middle East & Africa
11. Competitive Landscape
11.1. Introduction
11.2. Key Growth Strategies
11.3. Competitive Benchmarking
11.4. Market Share Analysis (2021)
12. Company Profiles (Business Overview, Financial Overview, Products Portfolio, Strategic Developments)
12.1. Idexx Laboratories, Inc.
12.2. Thermo Fisher Scientific Inc.
12.3. bioMérieux S.A.
12.4. Neogen Corporation
12.5. Biomedica Medizinprodukte GmbH & Co KG
12.6. VCA, Inc.
12.7. Novacyt Group
12.8. QIAGEN N.V.
12.9. Heska Corporation
12.10. BioChek B.V
13. Appendix
13.1. Questionnaire
13.2. Available Customization
List of Tables
Table 1 Global Veterinary Molecular Diagnostics Market Drivers: Impact Analysis (2022–2029)
Table 2 Global Veterinary Molecular Diagnostics Market Restraint: Impact Analysis (2022–2029)
Table 3 Global Veterinary Molecular Diagnostics Market Size, by Product, 2020–2029 (USD Million)
Table 4 Veterinary Molecular Diagnostics Market Size, by Country/Region, 2020–2029 (USD Million)
Table 5 Veterinary Molecular Diagnostics Kits and Reagents Market Size, by Country/Region, 2020–2029 (USD Million)
Table 6 Veterinary Molecular Diagnostics Instruments Market Size, by Country/Region, 2020–2029 (USD Million)
Table 7 Veterinary Molecular Diagnostics Software & Services Market Size, by Country/Region, 2020–2029 (USD Million)
Table 8 Global Veterinary Molecular Diagnostics Market Size, by Application, 2020–2029 (USD Million)
Table 9 Veterinary Molecular Diagnostics Market Size for Infectious Diseases, by Country/Region, 2020–2029 (USD Million)
Table 10 Veterinary Molecular Diagnostics Market Size for Metabolic Diseases, by Country/Region, 2020–2029 (USD Million)
Table 11 Veterinary Molecular Diagnostics Market Size for Genetics, by Country/Region, 2020–2029 (USD Million)
Table 12 Veterinary Molecular Diagnostics Market Size for Other Diseases, by Country/Region, 2020–2029 (USD Million)
Table 13 Global Veterinary Molecular Diagnostics Market Size, by Technology, 2020–2029 (USD Million)
Table 14 Veterinary PCR Based Diagnostics Market Size, by Country/Region, 2020–2029 (USD Million)
Table 15 Veterinary Microarray Based Diagnostics Market Size, by Country/Region, 2020–2029 (USD Million)
Table 16 Veterinary DNA Sequencing Based Diagnostics Market Size, by Country/Region, 2020–2029 (USD Million)
Table 17 Global Veterinary Molecular Diagnostics Market Size, by Animal Type, 2020–2029 (USD Million)
Table 18 Companion Animal Molecular Diagnostics Market Size, by Country/Region, 2020–2029 (USD Million)
Table 19 Livestock Animal Molecular Diagnostics Market Size, by Country/Region, 2020–2029 (USD Million)
Table 20 Global Veterinary Molecular Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 21 Veterinary Molecular Diagnostics Market Size for Hospitals, by Country/Region, 2020–2029 (USD Million)
Table 22 Veterinary Molecular Diagnostics Market Size for Clinical Laboratories, by Country/Region, 2020–2029 (USD Million)
Table 23 Veterinary Molecular Diagnostics Market Size for Research Institutes, by Country/Region, 2020–2029 (USD Million)
Table 24 Global Veterinary Molecular Diagnostics Market Size, by Country/Region, 2020–2029 (USD Million)
Table 25 North America: Veterinary Molecular Diagnostics Market Size, by Country, 2020–2029 (USD Million)
Table 26 North America: Veterinary Molecular Diagnostics Market Size, by Product, 2020–2029 (USD Million)
Table 27 North America: Veterinary Molecular Diagnostics Market Size, by Application, 2020–2029 (USD Million)
Table 28 North America: Veterinary Molecular Diagnostics Market Size, by Technology, 2020–2029 (USD Million)
Table 29 North America: Veterinary Molecular Diagnostics Market Size, by Animal Type, 2020–2029 (USD Million)
Table 30 North America: Veterinary Molecular Diagnostics Market Size, by End User, 2020–2029 (USD Million)
Table 31 U.S.: Veterinary Molecular Diagnostics Market Size by Product, 2020–2029 (USD Million)
Table 32 U.S: Veterinary Molecular Diagnostics Market Size by Application, 2020–2029 (USD Million)
Table 33 U.S.: Veterinary Molecular Diagnostics Market Size by Technology, 2020–2029 (USD Million)
Table 34 U.S.: Veterinary Molecular Diagnostics Market Size by Animal Type, 2020–2029 (USD Million)
Table 35 U.S.: Veterinary Molecular Diagnostics Market Size by End User, 2020–2029 (USD Million)
Table 36 Canada: Veterinary Molecular Diagnostics Market Size by Product, 2020–2029 (USD Million)
Table 37 Canada: Veterinary Molecular Diagnostics Market Size by Application, 2020–2029 (USD Million)
Table 38 Canada: Veterinary Molecular Diagnostics Market Size by Technology, 2020–2029 (USD Million)
Table 39 Canada: Veterinary Molecular Diagnostics Market Size by Animal Type, 2020–2029 (USD Million)
Table 40 Canada: Veterinary Molecular Diagnostics Market Size by End User, 2020–2029 (USD Million)
Table 41 Europe: Veterinary Molecular Diagnostics Market Size by Country/Region, 2020–2029 (USD Million)
Table 42 Europe: Veterinary Molecular Diagnostics Market Size by Product, 2020–2029 (USD Million)
Table 43 Europe: Veterinary Molecular Diagnostics Market Size by Application, 2020–2029 (USD Million)
Table 44 Europe: Veterinary Molecular Diagnostics Market Size by Technology, 2020–2029 (USD Million)
Table 45 Europe: Veterinary Molecular Diagnostics Market Size by Animal Type, 2020–2029 (USD Million)
Table 46 Europe: Veterinary Molecular Diagnostics Market Size by End User, 2020–2029 (USD Million)
Table 47 Germany: Veterinary Molecular Diagnostics Market Size by Product, 2020–2029 (USD Million)
Table 48 Germany: Veterinary Molecular Diagnostics Market Size by Application, 2020–2029 (USD Million)
Table 49 Germany: Veterinary Molecular Diagnostics Market Size by Technology, 2020–2029 (USD Million)
Table 50 Germany: Veterinary Molecular Diagnostics Market Size by Animal Type, 2020–2029 (USD Million)
Table 51 Germany: Veterinary Molecular Diagnostics Market Size by End User, 2020–2029 (USD Million)
Table 52 U.K.: Veterinary Molecular Diagnostics Market Size by Product, 2020–2029 (USD Million)
Table 53 U.K.: Veterinary Molecular Diagnostics Market Size by Application, 2020–2029 (USD Million)
Table 54 U.K.: Veterinary Molecular Diagnostics Market Size by Technology, 2020–2029 (USD Million)
Table 55 U.K.: Veterinary Molecular Diagnostics Market Size by Animal Type, 2020–2029 (USD Million)
Table 56 U.K.: Veterinary Molecular Diagnostics Market Size by End User, 2020–2029 (USD Million)
Table 57 France: Veterinary Molecular Diagnostics Market Size by Product, 2020–2029 (USD Million)
Table 58 France: Veterinary Molecular Diagnostics Market Size by Application, 2020–2029 (USD Million)
Table 59 France: Veterinary Molecular Diagnostics Market Size by Technology, 2020–2029 (USD Million)
Table 60 France: Veterinary Molecular Diagnostics Market Size by Animal Type, 2020–2029 (USD Million)
Table 61 France: Veterinary Molecular Diagnostics Market Size by End User, 2020–2029 (USD Million)
Table 62 Italy: Veterinary Molecular Diagnostics Market Size by Product, 2020–2029 (USD Million)
Table 63 Italy: Veterinary Molecular Diagnostics Market Size by Application, 2020–2029 (USD Million)
Table 64 Italy: Veterinary Molecular Diagnostics Market Size by Technology, 2020–2029 (USD Million)
Table 65 Italy: Veterinary Molecular Diagnostics Market Size by Animal Type, 2020–2029 (USD Million)
Table 66 Italy: Veterinary Molecular Diagnostics Market Size by End User, 2020–2029 (USD Million)
Table 67 Spain: Veterinary Molecular Diagnostics Market Size by Product, 2020–2029 (USD Million)
Table 68 Spain: Veterinary Molecular Diagnostics Market Size by Application, 2020–2029 (USD Million)
Table 69 Spain: Veterinary Molecular Diagnostics Market Size by Technology, 2020–2029 (USD Million)
Table 70 Spain: Veterinary Molecular Diagnostics Market Size by Animal Type, 2020–2029 (USD Million)
Table 71 Spain: Veterinary Molecular Diagnostics Market Size by End User, 2020–2029 (USD Million)
Table 72 RoE: Veterinary Molecular Diagnostics Market Size by Product, 2020–2029 (USD Million)
Table 73 RoE: Veterinary Molecular Diagnostics Market Size by Application, 2020–2029 (USD Million)
Table 74 RoE: Veterinary Molecular Diagnostics Market Size by Technology, 2020–2029 (USD Million)
Table 75 RoE: Veterinary Molecular Diagnostics Market Size by Animal Type, 2020–2029 (USD Million)
Table 76 RoE: Veterinary Molecular Diagnostics Market Size by End User, 2020–2029 (USD Million)
Table 77 Asia–Pacific: Veterinary Molecular Diagnostics Market Size by Country/Region, 2020–2029 (USD Million)
Table 78 Asia–Pacific: Veterinary Molecular Diagnostics Market Size by Product, 2020–2029 (USD Million)
Table 79 Asia–Pacific: Veterinary Molecular Diagnostics Market Size by Application, 2020–2029 (USD Million)
Table 80 Asia–Pacific: Veterinary Molecular Diagnostics Market Size by Technology, 2020–2029 (USD Million)
Table 81 Asia–Pacific: Veterinary Molecular Diagnostics Market Size by Animal Type, 2020–2029 (USD Million)
Table 82 Asia–Pacific: Veterinary Molecular Diagnostics Market Size by End User, 2020–2029 (USD Million)
Table 83 Japan: Veterinary Molecular Diagnostics Market Size by Product, 2020–2029 (USD Million)
Table 84 Japan: Veterinary Molecular Diagnostics Market Size by Application, 2020–2029 (USD Million)
Table 85 Japan: Veterinary Molecular Diagnostics Market Size by Technology, 2020–2029 (USD Million)
Table 86 Japan: Veterinary Molecular Diagnostics Market Size by Animal Type, 2020–2029 (USD Million)
Table 87 Japan: Veterinary Molecular Diagnostics Market Size by End User, 2020–2029 (USD Million)
Table 88 China: Veterinary Molecular Diagnostics Market Size by Product, 2020–2029 (USD Million)
Table 89 China: Veterinary Molecular Diagnostics Market Size by Application, 2020–2029 (USD Million)
Table 90 China: Veterinary Molecular Diagnostics Market Size by Technology, 2020–2029 (USD Million)
Table 91 China: Veterinary Molecular Diagnostics Market Size by Animal Type, 2020–2029 (USD Million)
Table 92 China: Veterinary Molecular Diagnostics Market Size by End User, 2020–2029 (USD Million)
Table 93 India: Veterinary Molecular Diagnostics Market Size by Product, 2020–2029 (USD Million)
Table 94 India: Veterinary Molecular Diagnostics Market Size by Application, 2020–2029 (USD Million)
Table 95 India: Veterinary Molecular Diagnostics Market Size by Technology, 2020–2029 (USD Million)
Table 96 India: Veterinary Molecular Diagnostics Market Size by Animal Type, 2020–2029 (USD Million)
Table 97 India: Veterinary Molecular Diagnostics Market Size by End User, 2020–2029 (USD Million)
Table 98 RoAPAC: Veterinary Molecular Diagnostics Market Size by Product, 2020–2029 (USD Million)
Table 99 RoAPAC: Veterinary Molecular Diagnostics Market Size by Application, 2020–2029 (USD Million)
Table 100 RoAPAC: Veterinary Molecular Diagnostics Market Size by Technology, 2020–2029 (USD Million)
Table 101 RoAPAC: Veterinary Molecular Diagnostics Market Size by Animal Type, 2020–2029 (USD Million)
Table 102 RoAPAC: Veterinary Molecular Diagnostics Market Size by End User, 2020–2029 (USD Million)
Table 103 Recent Developments by Company, 2019–2022
List of Figures
Figure 1 Key Stakeholders
Figure 2 Research Process
Figure 3 Key Secondary Sources
Figure 4 Primary Research Techniques
Figure 5 Key Executives Interviewed
Figure 6 Breakdown of Primary Interviews (Supply–Side & Demand–Side)
Figure 7 Market Size Estimation
Figure 8 Global Veterinary Molecular Diagnostics Market, by Product, 2022 Vs 2029 (USD Million)
Figure 9 Global Veterinary Molecular Diagnostics Market Size, by Application, 2022 Vs. 2029 (USD Million)
Figure 10 Global Veterinary Molecular Diagnostics Market Size, by Technology, 2022 Vs. 2029 (USD Million)
Figure 11 Global Veterinary Molecular Diagnostics Market Size, by Animal Type, 2022 Vs. 2029 (USD Million)
Figure 12 Global Veterinary Molecular Diagnostics Market Size, by End User, 2022 Vs. 2029 (USD Million)
Figure 13 Veterinary Molecular Diagnostics Market, by Region
Figure 14 Market Dynamics
Figure 15 Global Veterinary Molecular Diagnostics Market Size, by Product, 2022–2029 (USD Million)
Figure 16 Global Veterinary Molecular Diagnostics Market Size, by Application, 2022–2029 (USD Million)
Figure 17 Global Veterinary Molecular Diagnostics Market Size, by Technology, 2022–2029 (USD Million)
Figure 18 Global Veterinary Molecular Diagnostics Market Size, by Animal Type, 2022–2029 (USD Million)
Figure 19 Global Veterinary Molecular Diagnostics Market Size, by Technology, 2022–2029 (USD Million)
Figure 20 Global Veterinary Molecular Diagnostics Market Size, by End User, 2022–2029 (USD Million)
Figure 21 Global Veterinary Molecular Diagnostics Market Size, by Geography, 2022–2029 (USD Million)
Figure 22 North America: Veterinary Molecular Diagnostics Market Snapshot
Figure 23 Europe: Veterinary Molecular Diagnostics Market Snapshot
Figure 24 Asia-Pacific: Veterinary Molecular Diagnostics Market Snapshot
Figure 25 Key Growth Strategies Adopted by Leading Players, 2019–2022
Figure 26 Veterinary Molecular Diagnostics Market: Competitive Benchmarking
Figure 27 Market Share Analysis: Veterinary Molecular Diagnostics Industry, 2021
This report provides pre & post COVID-19 market estimates.
This report provides pre & post COVID-19 market estimates.
Published Date: Feb-2023
Published Date: Jan-2023
Published Date: Jun-2022
Published Date: May-2022
